WuXi STA, a subsidiary of WuXi AppTec, has opened a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus.   Created in response to the increasing demand for complex injection dosage forms, this new facility adds to the company’s fast-growing parenteral formulation capabilities and is yet another opportunity to enable customers as they develop and deliver better medicines for patients.   This new facility integrates multi-channe...